There is absolutely no justification for a market cap of $70 million for this company. They have a massive quarterly outlay on directors fees, development and the occasional unexplained transaction, and no income at all. Despite predictions of massive profits in years past, they currently do not even forecast any revenue figures. Maybe they'll make a few million dollars from the Malaysian contract... will it cover expenses even? Probably not, but who knows, maybe they'll even make a few million net profit (unlikely). So a realistic value at a generous PE would make it a 20-30 million dollar company (if all goes well). That would make it, what, 3-5 cents a share? A generous valuation in my opinion, but it shows how risky NBS is at it's current unsustainable share price.
- Forums
- ASX - By Stock
- now there are sixteen new offices in malaysia
There is absolutely no justification for a market cap of $70...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NBS (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online